Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announced a solicitation for lead plaintiffs in a securities fraud class action against Capricor Therapeutics. The complaint alleges Capricor made false statements regarding changes to the statistical analysis plan for Deramiocel and the FDA's agreement with those changes.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.